GOSS - Gossamer Bio GAAP EPS of -$0.74 misses by $0.04 August, 09 2022 08:30 AM Gossamer Bio Inc. Gossamer Bio press release ( NASDAQ: GOSS ): Q2 GAAP EPS of -$0.74 misses by $0.04 . Cash, cash equivalents and marketable securities as of June 30, 2022, were $222.2 million. For further details see: Gossamer Bio GAAP EPS of -$0.74 misses by $0.04